June Off to a Poor ...
Express Scripts (ESRX: NASDAQ)
$51.12 0.45 | 0.89%
06/04/12 - 10:40 AM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 46.13B | 44.97B | 24.75B | 21.98B |
| Cost of Sales | 42.66B | 41.77B | 22.21B | 19.84B |
| Gross Operating Profit | 3.46B | 3.20B | 2.54B | 2.14B |
| Selling, General, and Administrative Expenses | 898.20M | 887.30M | 932.00M | 760.40M |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income before D & A (EBITDA) | 2.57B | 2.32B | 1.61B | 1.38B |
| Depreciation & Amortization | 253.40M | 244.70M | 109.90M | 97.70M |
| Interest Income | 12.40M | 4.90M | 5.30M | 13.00M |
| Other Income - Net | 0.00 | 0.00 | 0.00 | -2.30M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 2.32B | 2.08B | 1.50B | 1.29B |
| Interest Expense | 299.70M | 167.10M | 194.40M | 77.60M |
| Pre-Tax Income | 2.02B | 1.91B | 1.31B | 1.21B |
| Income Taxes | 748.60M | 704.10M | 482.80M | 434.00M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 1.28B | 1.20B | 826.50M | 779.60M |
| Net Income From Discontinued Operations | 0.00 | -23.40M | 1.10M | -3.50M |
| Net Income From Total Operations | 1.28B | 1.18B | 827.60M | 776.10M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 1.28B | 1.18B | 827.60M | 776.10M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.28B | 1.20B | 826.50M | 779.60M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 1.28B | 1.20B | 826.50M | 779.60M |
| Basic EPS from Continuing Ops. | 2.55 | 2.24 | 1.57 | 1.57 |
| Basic EPS from Discontinued Ops. | 0.00 | -0.04 | 0.00 | -0.01 |
| Basic EPS from Total Operations | 2.55 | 2.20 | 1.57 | 1.56 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | -0.01 | 0.00 | 0.00 |
| Basic EPS, Total | 2.55 | 2.19 | 1.57 | 1.56 |
| Basic Normalized Net Income/Share | 2.55 | 2.24 | 1.57 | 1.57 |
| EPS fr Continuing Ops. | 2.53 | 2.21 | 1.56 | 1.55 |
| EPS fr Discontinued Ops | 0.00 | -0.04 | 0.00 | -0.01 |
| EPS fr Total Ops. | 2.53 | 2.17 | 1.56 | 1.55 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS, Total | 2.53 | 2.17 | 1.56 | 1.54 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.53 | 2.21 | 1.56 | 1.55 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ESRX
- Portfolio NameUser Type
- UserMoonPie
- ProLee Ainslie - Maverick Capital
- ProDaniel Loeb - Third Point
- ContributorStocks Rising On Unusual Vo...
- ProSteven Cohen - SAC Capital
- ProSteve Mandel - Lone Pine Ca...
- ProGeorge Soros
- UserJimboPhi
- UserCorporate Communication cla...
- ContributorTechnical Setups for the We...
Latest ESRX Headlines from TheStreet
- Express Scripts (ESRX): Today's Featured Health Services Loser 06.01.12 | 05:06 pm
- Express Scripts (ESRX): Today's Featured Health Services Winner 05.25.12 | 05:05 pm
- Express Scripts (ESRX): Today's Featured Health Services Loser 05.17.12 | 05:05 pm
- 8 Stocks Ripping Higher on Big Volume 05.11.12 | 01:05 pm
- Express Scripts Holding's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.11.12 | 12:05 pm
- Express Scripts (ESRX): Today's Featured Health Services Winner 05.10.12 | 05:05 pm
- The Week Ahead: PPI Data; Rackspace, Priceline Earnings
05.06.12 | 06:05 pm - Express Scripts (ESRX): Today's Featured Health Services Loser 05.03.12 | 05:05 pm
- Business Highlights 05.02.12 | 06:05 pm
- Express Scripts (ESRX): Today's Featured Health Services Loser 04.25.12 | 05:04 pm
Press Releases for ESRX
- United BioSource Corp Scientists To Present At 17th Annual ISPOR Meeting In Washington, DC June 2-6, 2012 - PR Newswire 06.01.12 | 12:06 pm
- Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior As Top Concern Of Benefit Providers - PR Newswire 05.17.12 | 07:05 am
- Failure To Take Medicine Linked To Unnecessary Hospital Visits, Especially For Medicare Patients Taking High Blood Pressure Or High Cholesterol Medications - PR Newswire 05.11.12 | 11:05 am
- Express Scripts To Present At Bank Of America Merrill Lynch Conference - PR Newswire 05.04.12 | 08:05 am
- Express Scripts Launches ScreenRx(SM), Industry's First Solution Combining Early Detection And Tailored Interventions To Address Nation's $317 Billion Problem Of Medication Nonadherence - PR Newswire 04.16.12 | 07:04 am
- Notice Of Redemption And Withdrawal Of Class Of Securities From Listing On The NYSE - PR Newswire 04.06.12 | 01:04 pm
- Express Scripts Announces First Quarter 2012 Earnings Conference Call - PR Newswire 04.05.12 | 03:04 pm
- Express Scripts And Medco Health Solutions Complete Merger; Will Address National Mandate For More Affordable, Higher Quality Healthcare - PR Newswire 04.02.12 | 08:04 am
- Express Scripts Research Shows Choosing Appropriate Medications Could Save Workers' Compensation Payers More Than $23.7 Million Annually - PR Newswire 03.19.12 | 08:03 am
- Express Scripts Unveils Comprehensive Fraud, Waste And Abuse Program For Workers' Compensation Clients - PR Newswire 02.27.12 | 08:02 am
Partner Headlines for ESRX
- Early Buzzers: Chesapeake Cleans House, Facebook Shares Bleed - Wall St. Cheat Sheet 06.04.12 | 11:06 am
- Walgreens Statement on Express Scripts Dispute - Benzinga 06.01.12 | 05:06 pm
- Healthcare Biz Recap: Express Scripts New Driver, Elan Pops - Wall St. Cheat Sheet 05.27.12 | 12:05 pm
- Goldman Sachs: Apple's a Darling, Amazon's a Risk - Wall St. Cheat Sheet 05.25.12 | 02:05 am
- Healthcare Biz Recap: GSK Shakes on Human Genome, Express Scripts Desires a Date Walgreen - Wall St. Cheat Sheet 05.23.12 | 11:05 am
- SXC And Catalyst Catch Fire In Express Scripts Shadow - Investor's Business Daily 05.18.12 | 02:05 pm
- Earnings Miss at Express Scripts - Analyst Blog - Zacks 05.11.12 | 09:05 am
- ESRX Loss Hurts Walgreen Again - Analyst Blog - Zacks 05.08.12 | 08:05 am
- Earnings Expectations for the Week of May 7 (DIS, M, CSCO) - Benzinga 05.06.12 | 08:05 am
- Drugstore Chain Ups Earnings Target After Competition Contract Issues - Seeking Alpha 05.04.12 | 09:05 am





